» Articles » PMID: 38470541

What Patients with Advanced Cancer Experience As Helpful in Navigating Their Life with a Long-term Response: a Qualitative Study

Overview
Specialties Critical Care
Oncology
Date 2024 Mar 12
PMID 38470541
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Despite improved survival for people with advanced cancer due to new medical treatments, a growing group of long-term responders (LTRs) has to learn to live with uncertainties that affect several life domains. At the core of their experience, they neither feel like a patient nor feel healthy. Despite growing awareness of LTRs' experiences, learning more about how they cope with their long-term response can provide insight into how to best support them. Our study aimed to gain a deeper understanding what LTRs experience as helpful in navigating life with a long-term response.

Methods: We conducted an exploratory qualitative study using thematic data analysis. Semi-structured in-depth interviews were conducted with 17 participants with advanced melanoma or lung cancer with confirmed response or long-term stable disease while on immuno- or targeted therapy.

Results: LTRs reported several strategies to navigate life with a long-term response, for example, by involving the social environment, seeing uncertainty as an opportunity, and being present in the moment. This helped them to reclaim a sense of control, alter their perspective, and reshape their lives according to their values.

Conclusion: Using different coping strategies enables LTRs to acknowledge both their sick and healthy side. Striking a healthy balance between being oriented on feeling sick or feeling healthy can help LTRs and their close others to navigate life with a long-term response. Healthcare professionals can provide support by recognizing whether LTRs are oriented at feeling sick or healthy, and by actively involving close others during medical appointments.

Citing Articles

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

Kolsteren E, Deuning-Smit E, Prins J, van der Graaf W, Kwakkenbos L, Custers J J Cancer Surviv. 2024; .

PMID: 39470942 DOI: 10.1007/s11764-024-01698-w.


"There is a life before and after cancer": experiences of resuming life and unmet care needs in stage I and II melanoma survivors.

Kamminga N, Kievits J, Wakkee M, van Loon S, Joosen M, Verver D Arch Dermatol Res. 2024; 316(9):645.

PMID: 39325191 PMC: 11427545. DOI: 10.1007/s00403-024-03376-4.


Resilience in the Face of Cancer: On the Importance of Defining and Studying Resilience as a Dynamic Process of Adaptation.

Schellekens M, Zwanenburg L, van der Lee M Curr Oncol. 2024; 31(7):4003-4014.

PMID: 39057169 PMC: 11276221. DOI: 10.3390/curroncol31070297.


Emotional Distress, Cognitive Complaints, and Care Needs among Advanced Cancer Survivors Treated with Immune Checkpoint Blockade: A Mixed-Method Study.

Vanlaer N, Dirven I, Neyns B, Rogiers A Cancers (Basel). 2024; 16(9).

PMID: 38730590 PMC: 11083145. DOI: 10.3390/cancers16091638.

References
1.
Stroebe M, Schut H . The dual process model of coping with bereavement: a decade on. Omega (Westport). 2010; 61(4):273-89. DOI: 10.2190/OM.61.4.b. View

2.
Langer S, Brown J, Syrjala K . Intrapersonal and interpersonal consequences of protective buffering among cancer patients and caregivers. Cancer. 2009; 115(18 Suppl):4311-25. PMC: 2762643. DOI: 10.1002/cncr.24586. View

3.
Gonzalez-Fernandez S, Fernandez-Rodriguez C . Acceptance and Commitment Therapy in Cancer: Review of Applications and Findings. Behav Med. 2018; 45(3):255-269. DOI: 10.1080/08964289.2018.1452713. View

4.
Bottaro R, Faraci P . The influence of socio-demographics and clinical characteristics on coping strategies in cancer patients: a systematic review. Support Care Cancer. 2022; 30(11):8785-8803. DOI: 10.1007/s00520-022-07267-0. View

5.
Temel J, Greer J, Muzikansky A, Gallagher E, Admane S, Jackson V . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363(8):733-42. DOI: 10.1056/NEJMoa1000678. View